Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


Articles published in J Clin Psychiatry

Retrieve available abstracts of 84 articles:
HTML format
Text format



Single Articles


    May 2018
  1. KEEFE RSE, Harvey PD, Khan A, Saoud JB, et al
    Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled Trial.
    J Clin Psychiatry. 2018;79.
    PubMed     Text format     Abstract available


    April 2018
  2. LEE EE, Martin AS, Tu X, Palmer BW, et al
    Childhood Adversity and Schizophrenia: The Protective Role of Resilience in Mental and Physical Health and Metabolic Markers.
    J Clin Psychiatry. 2018;79.
    PubMed     Text format     Abstract available


  3. HOU CL, Chen MY, Cai MY, Chen ZL, et al
    Antipsychotic-Free Status in Community-Dwelling Patients With Schizophrenia in China: Comparisons Within and Between Rural and Urban Areas.
    J Clin Psychiatry. 2018;79.
    PubMed     Text format     Abstract available


    March 2018
  4. TAKEUCHI H, Fathi A, Thiyanavadivel S, Agid O, et al
    Can Aripiprazole Worsen Psychosis in Schizophrenia? A Meta-Analysis of Double-Blind, Randomized, Controlled Trials.
    J Clin Psychiatry. 2018;79.
    PubMed     Text format     Abstract available


    November 2017
  5. TSOUTSOULAS C, Mulsant BH, Kumar S, Ghazala Z, et al
    Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
    J Clin Psychiatry. 2017 Nov 28. doi: 10.4088/JCP.17m11523.
    PubMed     Text format     Abstract available


  6. ANDRADE C
    Memantine as an Augmentation Treatment for Schizophrenia: Limitations of Meta-Analysis for Evidence-Based Evaluation of Research.
    J Clin Psychiatry. 2017 Nov 21. doi: 10.4088/JCP.17f11998.
    PubMed     Text format     Abstract available


  7. DEAN DJ, Bryan AD, Newberry R, Gupta T, et al
    A Supervised Exercise Intervention for Youth at Risk for Psychosis: An Open-Label Pilot Study.
    J Clin Psychiatry. 2017 Nov 21. doi: 10.4088/JCP.16m11365.
    PubMed     Text format     Abstract available


  8. MEKORI-DOMACHEVSKY E, Taler M, Shoenfeld Y, Gurevich M, et al
    Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits.
    J Clin Psychiatry. 2017 Nov 14. pii: 16m11207. doi: 10.4088/JCP.16m11207.
    PubMed     Text format     Abstract available


  9. TINKELMAN A, Hill EA, Deligiannidis KM
    Management of New Onset Psychosis in the Postpartum Period.
    J Clin Psychiatry. 2017 Nov 7. pii: 17ac11880. doi: 10.4088/JCP.17ac11880.
    PubMed     Text format    


  10. DOWNS JM, Lechler S, Dean H, Sears N, et al
    The Association Between Comorbid Autism Spectrum Disorders and Antipsychotic Treatment Failure in Early-Onset Psychosis: A Historical Cohort Study Using Electronic Health Records.
    J Clin Psychiatry. 2017 Nov 7. pii: 16m11422. doi: 10.4088/JCP.16m11422.
    PubMed     Text format     Abstract available


  11. PERKINS DO
    Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics?
    J Clin Psychiatry. 2017;78:e1431.
    PubMed     Text format     Abstract available


    September 2017
  12. MCEVOY JP, Risinger R, Mykhnyak S, Du Y, et al
    Durability of Therapeutic Response With Long-Term Aripiprazole Lauroxil Treatment Following Successful Resolution of an Acute Episode of Schizophrenia.
    J Clin Psychiatry. 2017 Sep 19. pii: 17m11625. doi: 10.4088/JCP.17m11625.
    PubMed     Text format     Abstract available


  13. HAIG GM, Wang D, Zhao J, Othman AA, et al
    Efficacy and Safety of the alpha7-Nicotinic Acetylcholine Receptor Agonist ABT-126 in the Treatment of Cognitive Impairment Associated With Schizophrenia: Results From a Phase 2b Randomized Controlled Study in Smokers.
    J Clin Psychiatry. 2017 Sep 12. pii: 16m11162. doi: 10.4088/JCP.16m11162.
    PubMed     Text format     Abstract available


  14. PUIG O, Baeza I, de la Serna E, Cabrera B, et al
    Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset.
    J Clin Psychiatry. 2017 Sep 12. pii: 16m11122. doi: 10.4088/JCP.16m11122.
    PubMed     Text format     Abstract available


  15. SULTAN RS, Olfson M, Correll CU, Duncan EJ, et al
    Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring.
    J Clin Psychiatry. 2017;78:e933-e939.
    PubMed     Text format     Abstract available


    June 2017
  16. WEIDEN PJ, Kim E, Bermak J, Turkoz I, et al
    Does Half-Life Matter After Antipsychotic Discontinuation? A Relapse Comparison in Schizophrenia With 3 Different Formulations of Paliperidone.
    J Clin Psychiatry. 2017 Jun 20. pii: 16m11308. doi: 10.4088/JCP.16m11308.
    PubMed     Text format     Abstract available


    May 2017
  17. WEISER M, Levi L, Burshtein S, Hagin M, et al
    Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.
    J Clin Psychiatry. 2017 May 23. pii: 15m10498. doi: 10.4088/JCP.15m10498.
    PubMed     Text format     Abstract available


  18. TOSATO S, Albert U, Tomassi S, Iasevoli F, et al
    A Systematized Review of Atypical Antipsychotics in Pregnant Women: Balancing Between Risks of Untreated Illness and Risks of Drug-Related Adverse Effects.
    J Clin Psychiatry. 2017;78:e477-e489.
    PubMed     Text format     Abstract available


  19. BERNARDINI F, Attademo L, Cleary SD, Luther C, et al
    Risk Prediction Models in Psychiatry: Toward a New Frontier for the Prevention of Mental Illnesses.
    J Clin Psychiatry. 2017;78:572-583.
    PubMed     Text format     Abstract available


    April 2017
  20. HAGEN JM, Sutterland AL, Koeter MW, Lutter R, et al
    Advanced Glycation End Products in Recent-Onset Psychosis Indicate Early Onset of Cardiovascular Risk.
    J Clin Psychiatry. 2017 Apr 25. doi: 10.4088/JCP.16m10972.
    PubMed     Text format     Abstract available


    March 2017
  21. ZHENG W, Xiang YT, Yang XH, Xiang YQ, et al
    Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.
    J Clin Psychiatry. 2017 Mar 28. doi: 10.4088/JCP.16r10782.
    PubMed     Text format     Abstract available


  22. KASTER TS, Daskalakis ZJ, Blumberger DM
    Clinical Effectiveness and Cognitive Impact of Electroconvulsive Therapy for Schizophrenia: A Large Retrospective Study.
    J Clin Psychiatry. 2017 Mar 14. doi: 10.4088/JCP.16m10686.
    PubMed     Text format     Abstract available


  23. GERRETSEN P, Voineskos AN, Graff-Guerrero A, Menon M, et al
    Insight Into Illness and Cognition in Schizophrenia in Earlier and Later Life.
    J Clin Psychiatry. 2017 Mar 14. doi: 10.4088/JCP.16m10741.
    PubMed     Text format     Abstract available


    February 2017
  24. TAKEUCHI H, Lee J, Fervaha G, Foussias G, et al
    Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.
    J Clin Psychiatry. 2017;78:223-228.
    PubMed     Text format     Abstract available


    January 2017
  25. JENSEN KG, Correll CU, Ruda D, Klauber DG, et al
    Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial.
    J Clin Psychiatry. 2017 Jan 17. doi: 10.4088/JCP.15m10479.
    PubMed     Text format     Abstract available


  26. HAUSER M, Zhang JP, Sheridan EM, Burdick KE, et al
    Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis.
    J Clin Psychiatry. 2017;78:e28-e40.
    PubMed     Text format     Abstract available


    December 2016
  27. HAMDANI N, Daban-Huard C, Godin O, Laouamri H, et al
    Effects of Cumulative Herpesviridae and Toxoplasma gondii Infections on Cognitive Function in Healthy, Bipolar, and Schizophrenia Subjects.
    J Clin Psychiatry. 2016 Dec 6. doi: 10.4088/JCP.15m10133.
    PubMed     Text format     Abstract available


  28. ANDRADE C
    Antipsychotic Drugs in Schizophrenia: Relative Effects in Patients With and Without Treatment Resistance.
    J Clin Psychiatry. 2016;77:e1656-e1660.
    PubMed     Text format     Abstract available


  29. GUINA J, Gupta A, Langleben DD, Elman I, et al
    Clinical Correlates of Oral Glucose Tolerance Test Performance in Olanzapine-Treated Patients with Schizophrenia or Schizoaffective Disorder.
    J Clin Psychiatry. 2016;77:e1650-e1651.
    PubMed     Text format    


  30. WEAMER EA, DeMichele-Sweet MA, Cloonan YK, Lopez OL, et al
    Incident Psychosis in Subjects With Mild Cognitive Impairment or Alzheimer's Disease.
    J Clin Psychiatry. 2016;77:e1564-e1569.
    PubMed     Text format     Abstract available


  31. IWATA Y, Nakajima S, Caravaggio F, Suzuki T, et al
    Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With Schizophrenia.
    J Clin Psychiatry. 2016;77:e1557-e1563.
    PubMed     Text format     Abstract available


    November 2016
  32. O'DONNELL CP, Allott KA, Murphy BP, Yuen HP, et al
    Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.
    J Clin Psychiatry. 2016 Nov 8. doi: 10.4088/JCP.15m10185.
    PubMed     Text format     Abstract available


  33. ZHANG C, Chen MJ, Wu GJ, Wang ZW, et al
    Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
    J Clin Psychiatry. 2016;77:e1460-e1466.
    PubMed     Text format     Abstract available


    October 2016
  34. BRADFORD DW, Goulet J, Hunt M, Cunningham NC, et al
    A Cohort Study of Mortality in Individuals With and Without Schizophrenia After Diagnosis of Lung Cancer.
    J Clin Psychiatry. 2016 Oct 25. doi: 10.4088/JCP.15m10281.
    PubMed     Text format     Abstract available


  35. TANG C, Subramaniam M, Ng BT, Abdin E, et al
    Clozapine Use in First-Episode Psychosis: The Singapore Early Psychosis Intervention Programme (EPIP) Perspective.
    J Clin Psychiatry. 2016 Oct 11. doi: 10.4088/JCP.15m10063.
    PubMed     Text format     Abstract available


  36. SAKURAI H, Suzuki T, Bies RR, Pollock BG, et al
    Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial.
    J Clin Psychiatry. 2016;77:1381-1390.
    PubMed     Text format     Abstract available


    September 2016
  37. BURGERHOUT KM, Kamperman AM, Roza SJ, Lambregtse-Van den Berg MP, et al
    Functional Recovery After Postpartum Psychosis: A Prospective Longitudinal Study.
    J Clin Psychiatry. 2016 Sep 13. doi: 10.4088/JCP.15m10204.
    PubMed     Text format     Abstract available


  38. ANDRADE C
    Cardiometabolic Risks in Schizophrenia and Directions for Intervention, 3: Psychopharmacological Interventions.
    J Clin Psychiatry. 2016;77:e1090-e1094.
    PubMed     Text format     Abstract available


  39. CANGA E, Puerto M, Ortega L, Sole M, et al
    Parental Antecedents of Psychosis Are Associated With Severity of Positive and Negative Symptoms in Schizophrenia Patients.
    J Clin Psychiatry. 2016;77:1201-1202.
    PubMed     Text format    


  40. MISDRAHI D, Tessier A, Swendsen J, Berna F, et al
    Determination of Adherence Profiles in Schizophrenia Using Self-Reported Adherence: Results From the FACE-SZ Dataset.
    J Clin Psychiatry. 2016;77:e1130-e1136.
    PubMed     Text format     Abstract available


    August 2016
  41. NASRALLAH HA, Newcomer JW, Risinger R, Du Y, et al
    Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia.
    J Clin Psychiatry. 2016 Aug 30. doi: 10.4088/JCP.15m10467.
    PubMed     Text format     Abstract available


  42. YOUNG-XU Y, Duh MS, Muser E, DerSarkissian M, et al
    Impact of Paliperidone Palmitate versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans with Schizophrenia.
    J Clin Psychiatry. 2016 Aug 30. doi: 10.4088/JCP.16m10745.
    PubMed     Text format     Abstract available


  43. ANDRADE C
    Cardiometabolic Risks in Schizophrenia and Directions for Intervention, 2: Nonpharmacological Interventions.
    J Clin Psychiatry. 2016;77:e964-e967.
    PubMed     Text format     Abstract available


  44. NOTARAS M, Hill RA, Buuse MV
    Dissecting a Genomic Role of BDNF in Schizophrenia and Psychosis.
    J Clin Psychiatry. 2016;77:e1029-e1031.
    PubMed     Text format    


  45. ZHANG XY, Chen DC, Tan YL, Tan S, et al
    BDNF Polymorphisms Are Associated With Cognitive Performance in Schizophrenia Patients Versus Healthy Controls.
    J Clin Psychiatry. 2016;77:e1011-e1018.
    PubMed     Text format     Abstract available


    July 2016
  46. LOEBEL A, Silva R, Goldman R, Watabe K, et al
    Lurasidone Dose Escalation in Early Nonresponding Patients With Schizophrenia: A Randomized, Placebo-Controlled Study.
    J Clin Psychiatry. 2016 Jul 19. doi: 10.4088/JCP.16m10698.
    PubMed     Text format     Abstract available


  47. ANDRADE C
    Cardiometabolic Risks in Schizophrenia and Directions for Intervention, 1: Magnitude and Moderators of the Problem.
    J Clin Psychiatry. 2016;77:e844-7.
    PubMed     Text format     Abstract available


    June 2016
  48. CORRELL CU, Maayan L, Kane J, Hert M, et al
    Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials.
    J Clin Psychiatry. 2016;77:e746-e756.
    PubMed     Text format     Abstract available


  49. ANDRADE C
    Cannabis and Neuropsychiatry, 2: The Longitudinal Risk of Psychosis as an Adverse Outcome.
    J Clin Psychiatry. 2016;77:e739-e742.
    PubMed     Text format     Abstract available


    May 2016
  50. TOHEN M, Khalsa HK, Salvatore P, Zarate CA Jr, et al
    The McLean-Harvard First-Episode Project: early course in 114 cases of first-episode nonaffective psychoses.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  51. ALAMEDA L, Golay P, Baumann PS, Ferrari C, et al
    Age at the time of exposure to trauma modulates the psychopathological profile in patients with early psychosis.
    J Clin Psychiatry. 2016;77:e612-8.
    PubMed     Text format     Abstract available


  52. SUN L, Qing Y, Yang X, Yang C, et al
    Gene expression profiling of the xMHC region reveals 9 candidate genes in schizophrenia.
    J Clin Psychiatry. 2016;77:e597-9.
    PubMed     Text format    


  53. WEIDEN PJ
    How many treatments before clozapine? medication choices across the spectrum of treatment resistance in schizophrenia.
    J Clin Psychiatry. 2016;77:e594-6.
    PubMed     Text format    


  54. WU CS, Wang SC, Yeh IJ, Liu SK, et al
    Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders.
    J Clin Psychiatry. 2016;77:e573-9.
    PubMed     Text format     Abstract available


  55. FONTANELLA CA, Campo JV, Phillips GS, Hiance-Steelesmith DL, et al
    Benzodiazepine use and risk of mortality among patients with schizophrenia: a retrospective longitudinal study.
    J Clin Psychiatry. 2016;77:661-7.
    PubMed     Text format     Abstract available


    April 2016
  56. CLOUTIER M, Sanon Aigbogun M, Guerin A, Nitulescu R, et al
    The economic burden of schizophrenia in the United States in 2013.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  57. LOZANO R, Franco ME, Marin R, Santacruz MJ, et al
    Anemia among schizophrenic patients: influence of clozapine and C-reactive protein.
    J Clin Psychiatry. 2016;77:e467.
    PubMed     Text format    


  58. WEHLER CA, Preskorn SH
    High false-positive rate of a putative biomarker test to aid in the diagnosis of schizophrenia.
    J Clin Psychiatry. 2016;77:e451-6.
    PubMed     Text format     Abstract available


    March 2016
  59. SCHOOLER NR, Marder SR, Chengappa KN, Petrides G, et al
    Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  60. ROCHON-TERRY G, Gruneir A, Seeman MV, Ray JG, et al
    Hospitalizations and emergency department visits for psychiatric illness during and after pregnancy among women with schizophrenia.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  61. WIDSCHWENDTER CG, Rettenbacher MA, Kemmler G, Edlinger M, et al
    Bilirubin concentration correlates with positive symptoms in patients with schizophrenia.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  62. KANTROWITZ JT, Sharif Z, Medalia A, Keefe RS, et al
    A multicenter, rater-blinded, randomized controlled study of auditory processing-focused cognitive remediation combined with open-label lurasidone in patients with schizophrenia and schizoaffective disorder.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


    February 2016
  63. HUI L, Han M, Huang XF, Ye MJ, et al
    Association between DbetaH 5'-insertion/deletion polymorphism and cognition in patients with chronic schizophrenia.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  64. DRAKE RJ, Addington J, Viswanathan AC, Lewis SW, et al
    How age and gender predict illness course in a first-episode nonaffective psychosis cohort.
    J Clin Psychiatry. 2016.
    PubMed     Text format     Abstract available


  65. MILLER BJ, Dias JK, Lemos HP, Buckley PF, et al
    An open-label, pilot trial of adjunctive tocilizumab in schizophrenia.
    J Clin Psychiatry. 2016;77:275-6.
    PubMed     Text format    


  66. VINOGRADOV S, Schulz SC
    Behavioral and emerging pharmacologic treatment options for cognitive impairment in schizophrenia.
    J Clin Psychiatry. 2016;77 Suppl 2:12-6.
    PubMed     Text format     Abstract available


  67. GREEN MF
    Impact of cognitive and social cognitive impairment on functional outcomes in patients with schizophrenia.
    J Clin Psychiatry. 2016;77 Suppl 2:8-11.
    PubMed     Text format     Abstract available


  68. SCHULZ SC, Murray A
    Assessing cognitive impairment in patients with schizophrenia.
    J Clin Psychiatry. 2016;77 Suppl 2:3-7.
    PubMed     Text format     Abstract available


  69. HIPPMAN C, Ringrose A, Inglis A, Cheek J, et al
    A pilot randomized clinical trial evaluating the impact of genetic counseling for serious mental illnesses.
    J Clin Psychiatry. 2016;77:e190-8.
    PubMed     Text format     Abstract available


    January 2016
  70. BORLIDO C, Remington G, Graff-Guerrero A, Arenovich T, et al
    Switching from 2 antipsychotics to 1 antipsychotic in schizophrenia: a randomized, double-blind, placebo-controlled study.
    J Clin Psychiatry. 2016;77:e14-20.
    PubMed     Text format     Abstract available


  71. DIMITROV DH, Lee S, Yantis J, Honaker C, et al
    Elevated serum levels of high-sensitivity C-reactive proteins are associated with severe delusional symptoms in a subgroup of patients with schizophrenia.
    J Clin Psychiatry. 2016;77:131-2.
    PubMed     Text format    


  72. CITROME L, Durgam S, Lu K, Ferguson P, et al
    The effect of cariprazine on hostility associated with schizophrenia: post hoc analyses from 3 randomized controlled trials.
    J Clin Psychiatry. 2016;77:109-15.
    PubMed     Text format     Abstract available


  73. LEO RJ, DuBois RL
    A case of olfactory groove meningioma misdiagnosed as schizophrenia.
    J Clin Psychiatry. 2016;77:67-8.
    PubMed     Text format     Abstract available


  74. CORRELL CU, Citrome L, Haddad PM, Lauriello J, et al
    The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence.
    J Clin Psychiatry. 2016;77.
    PubMed     Text format     Abstract available


    December 2015
  75. ZHANG XY, Fan FM, Chen DC, Tan YL, et al
    Extensive white matter abnormalities and clinical symptoms in drug-naive patients with first-episode schizophrenia: a voxel-based diffusion tensor imaging study.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  76. MAYORAL-VAN SON J, Ortiz-Garcia de la Foz V, Martinez-Garcia O, Moreno T, et al
    Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  77. DURGAM S, Cutler AJ, Lu K, Migliore R, et al
    Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, phase 3, randomized, double-blind, placebo- and active-controlled trial.
    J Clin Psychiatry. 2015;76:e1574-82.
    PubMed     Text format     Abstract available


    November 2015
  78. HUNG GC, Liu HC, Yang SY, Pan CH, et al
    Antipsychotic reexposure and recurrent pneumonia in schizophrenia: a nested case-control study.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  79. GERSTENBERG M, Hauser M, Al-Jadiri A, Sheridan EM, et al
    Frequency and correlates of DSM-5 attenuated psychosis syndrome in a sample of adolescent inpatients with nonpsychotic psychiatric disorders.
    J Clin Psychiatry. 2015;76:e1449-58.
    PubMed     Text format     Abstract available


    October 2015
  80. PARELLADA M, Castro-Fornieles J, Gonzalez-Pinto A, Pina-Camacho L, et al
    Predictors of functional and clinical outcome in early-onset first-episode psychosis: the child and adolescent first episode of psychosis (CAFEPS) study.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  81. LURIE I, Yang YX, Haynes K, Mamtani R, et al
    Antibiotic exposure and the risk for depression, anxiety, or psychosis: a nested case-control study.
    J Clin Psychiatry. 2015.
    PubMed     Text format     Abstract available


  82. VAN SCHEPENDOM J, Yu W, Gielen J, Laton J, et al
    Do advanced statistical techniques really help in the diagnosis of the metabolic syndrome in patients treated with second-generation antipsychotics?
    J Clin Psychiatry. 2015;76:e1292-9.
    PubMed     Text format     Abstract available


    September 2015
  83. DAVIS JM, Ramsden CE
    Do antipsychotics cause hip fractures? Promise and pitfalls of big data.
    J Clin Psychiatry. 2015;76:e1155-6.
    PubMed     Text format    


    August 2015
  84. RANNING A, Munk Laursen T, Thorup A, Hjorthoj C, et al
    Serious mental illness and disrupted caregiving for children: a nationwide, register-based cohort study.
    J Clin Psychiatry. 2015;76:e1006-14.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: